Paul Caltagirone
- Prostate Cancer
In the early 2000s I was a real estate agent living and working in Ocean County, New Jersey.
Call 888-369-2427
David Y.T. Chen, MD, FACS
Clinical Locations
-
Fox Chase Cancer Center333 Cottman Avenue
Philadelphia, PA 19111
Phone: 888-369-2427
-
Fox Chase - East Norriton2701 Dekalb Pike
East Norriton, PA 19401
Phone: 888-369-2427
-
Fox Chase Cancer Center - Huntingdon Pike8 Huntingdon Pike
Rockledge, PA 19046
Phone: 888-369-2427
Professor, Department of Urology
Associate Director, Urologic Oncology Fellowship Program
Associate Chief Academic Officer
Carol and Louis Della Penna Chair in Urologic Oncology
Specialties
- Urology
Areas of Expertise
Bladder Cancer, Prostate Cancer, Urethral Cancer, Adrenal Tumor, Penile Cancer, Ureteral Cancer, Kidney Cancer, Testicular Cancer
Treatment Focus
Urinary Diversions, Minimally Invasive Surgical Techniques - Laparoscopic, Robotic Surgery, Robotic Surgery and Urologic cancer ablation therapy (cryosurgery or HIFU)
Research Program
Distinctions
Treatment Philosophy
I am a urologic oncologist specializing in surgical treatment of cancers of the genitourinary tract. I have extensive experience with laparoscopic and minimally invasive surgical techniques and apply these approaches routinely to reduce the pain, recovery time, and complications associated with traditional open surgery.
I am skilled in nerve-sparing and organ-reconstructive surgery essential for preserving normal functions when treating prostate, testis, bladder and kidney cancer. I am sensitive to the particular issues regarding the diagnosis of genitourinary cancer and its subsequent treatment, including its physical and emotional effects on the patient and their family and support system.
I recognize each person is unique and requires a treatment individually tailored to them to achieve successful cancer treatment, limited treatment-related side effects and maintained quality of life.
Educational Background
- Fellow/National Institutes of Health Research Scholar, Howard Hughes Medical Institute, Bethesda, MD
- Fellow, Urologic Oncology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
- Resident, Urology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
MD, Weill Cornell Medical Center, Cornell University, New York, NY, 1997
Certifications
- American Board of Urology
Memberships
- Society of Laparoendoscopic Surgeons
- American Urological Association
- Philadelphia Urological Society
- Eastern Cooperative Oncology Group (ECOG)
- Society of Urologic Oncology
Honors & Awards
- Philadelphia Magazine Top Doctors, 2011-20, 2023-2024
- Main Line Today Top Doctors, 2018-2019
- Best Doctors in America® , 2019-2020, Urology
- America’s Top Doctors®, 2011-18
Lee Bentz
- Prostate Cancer
I was treated for prostate cancer in 2016, getting radiation therapy near where I live in Gettysburg, Pennsylvania. It worked for a while, but not long enough, because in 2022 my PSA level started going up again.
Gary Cavallo
- Prostate Cancer
At 73, I’m totally invested in my health and vigilant about keeping up with my doctors’ visits. When I went to my primary care physician in 2020, he alerted me that my PSA level was up, an indication that I had a problem with my prostate. I know the normal range is from 1 to 4. Mine was 5.2. “We’ll take another PSA down the road,” the doctor said. We did another one, and that was 5.6.
Peter Grove
- Bladder Cancer
- Prostate Cancer
- Ureteral Cancer
Nineteen years ago, just after I turned 60, I was diagnosed with bladder cancer. I had noticed some blood in my urine, and the first doctor I talked to told me not to worry about it. Then over the next few months it got worse, and I decided to go to Fox Chase Cancer Center.
Selected Publications
Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol, 199(5):1238-44, 2018. PubMed
Martin JM, Handorf EA, Price RA, Cherian G, Buyyounouski MK, et al. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2015; 40(3):186-9. NIHMSID: NIHMS656177 PubMed
Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy. Corcoran AT, Kaffenberger SD, Clark PE, Walton J, Handorf E, et al. BJU international. 2015; 116(3):351-7. PubMed
Patient comments